This differential binding was supported by in vitro data investigating nectin-4–expressing tumor cell lines versus keratinocytes from healthy donors, including flow cytometry–based extracellular staining, IHC on frozen tissues, fluorescence-based evaluation of internalization, and, most importantly, in vitro cytotoxicity assays with α-amanitin as a payload. Here, NECTIN4 is linked to neoplasm.